Remote Monitoring and Management of High-Risk Patients Being Started on Antineoplastic Treatment
Notice bibliographique
Résumé
Background Suboptimal management of cancer-related symptoms can lead to potentially preventable emergency department visits. Early detection and management of these symptoms leads to improved patient outcomes. The goal of this program is to capture symptom data on a daily cadence from patients beginning started on antineoplastic treatment and make these data available to staff who would intervene with the aim of mitigating symptom escalation. The aims of this pilot were patient acceptance of automated questionnaires, use of data by clinical staff, and integration of digital tools into workflows. Objective The objective was development and initial evaluation of a digitally enabled program to monitor and manage symptoms of cancer patients being started on treatment with antineoplastic drugs. Methods Memorial Sloan Kettering Cancer Center (MSKCC) patients being started on antineoplastic treatment were eligible for inclusion. The technology supporting the program included: (i) a predictive model identifying patients at high risk for emergency department visit in the next 6 months, (ii) a patient portal enabling symptom questionnaires to be sent to enrolled patients, (iii) an internally developed application that allows staff to review and trend symptom data, (iv) “alerts” for concerning symptoms that are sent to a dedicated team of oncology registered nurses and nurse practitioners, and (v) a secure messaging platform for communication between staff and patients. The predictive model runs nightly to identify eligible patients. Physicians review the risk information and decide whether to enroll each patient. Enrolled patients receive a daily patient-reported outcome questionnaire to capture symptoms. Alerts are generated based on the patient’s response to the symptom questions. The team reviews symptom data and interacts with the patient via phone, secure messaging, or televisits. The team collaborates with the primary oncology team as appropriate. Results The program went live in October 2018. Fifteen medical oncologists are participating in the pilot. As of June 21, 2019, 302 patients have been evaluated by the predictive model, of which 53 have been high risk and 249 have been low risk. Physicians have enrolled a total of 86 patients. Enrolled patients have completed 4198 out of 7287 symptom questionnaires, for a completion rate of 57.6%. Of the 4198 questionnaires, 1638 have generated a “red alert” (severe) symptom. Over 1200 secure messages have been exchanged between patients and staff. Lessons learned include: (i) patient acceptance of daily questionnaires has been high, (ii) the use of alerts assists the team in proactively managing participating patients, and (iii) patients and caregivers are reporting that they find the program valuable. The pilot demonstrated that daily symptom monitoring through a technology-enabled platform and a dedicated team is feasible and we are examining how the program might be scaled across our organization. Conclusions Through the use of automated symptom questionnaires and various bidirectional communication channels, remote monitoring and management of symptoms in cancer patients is feasible. This program enables providers at MSKCC to have visibility into patient symptomatology between visits and improves our understanding of the patient’s needs. The workflows of the staff monitoring the symptoms and how best to coordinate symptom management across multiple providers are areas of ongoing refinement.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».